Vascular and Psychophysical Effects of Topical Capsaicin Application to Orofacial Tissues

Aims: To characterize and contrast human sensory and vascular changes produced by topical application of the algesic chemical capsaicin to the glabrous lips and tongue. Methods: Applications of 1% capsaicin or vehicle cream to the glabrous lips and tongue were randomized between two two-trial sessions. The capsaicin trial followed the vehicle trial for each session. Before and 5, 15, and 30 minutes after capsaicin or vehicle cream application, six parameters were recorded from the glabrous lips or the tongue dorsum: (1) burning pain intensity, as measured on a visual analog scale; (2) burning pain area, as indicated by subjects on an orofacial drawing; (3) mechanical sensitivity, as measured by a von Frey filament; (4) visual flare; (5) blood flow and temperature, as measured by laser-Doppler imaging and thermography, respectively; and (6) areas of increased temperature (hot spots), as calculated by a digital tracer from the thermographs. Data were analyzed by ANOVAs and Pearson’s correlations. Results: Compared to vehicle application, capsaicin elicited burning pain, increases in blood flow and temperature, but no change in mechanical sensitivity in the glabrous lips or tongue. Greater increases in blood flow and temperature paralleled more intense burning pain and larger areas of perceived pain for the lips compared to the tongue. The location of distinct areas of increased temperature within the orofacial area differed between the capsaicinlip and capsaicin-tongue trials. Conclusion: The several differences between these responses to noxious stimulation of the glabrous lips and tongue may have implications for examinations of orofacial somatosensory functions.

capsaicin; laser-Doppler imaging; orofacial pain; thermography

1. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997; 389:816–824.

2. Caterina MJ, Julius D. The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487–517.

3. Kenins P. Responses of single nerve fibres to capsaicin applied to the skin. Neurosci Lett 1982;29:83–88.

4. LaMotte RH, Lundberg LE, Torebjork HE. Pain, hyperalgesia, and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 1992; 448:749–764.

5. Beydoun A, Dyke DB, Morrow TJ, Casey KL. Topical capsaicin selectively attenuates heat pain and A delta fiber-mediated laser-evoked potentials. Pain 1996; 65:189–196.

6. Magerl W, Fuchs PN, Meyer RA, Treede RD. Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain 2001;124:1754–1764.

7. Rau KK, Jiang N, Johnson RD, Cooper BY. Heat sensitization in skin and muscle nociceptors expressing distinct combinations of TRPV1 and TRPV2 protein. J Neurophysiol 2007;97:2651–2662.

8. Baumann TK, Simone DA, Shain CN, LaMotte RH. Neurogenic hyperalgesia: The search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol 1991;66:212–227.

9. Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989;38:99–107.

10. Simone DA, Ochoa J. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 1991;47:285–294.

11. Serra J, Campero M, Ochoa J. Flare and hyperalgesia after intradermal capsaicin injection in human skin. J Neurophysiol 1998;80:2801–2810.

12. Liu M, Max MB, Robinovitz E, Gracely RH, Bennett GJ. The human capsaicin model of allodynia and hyperalgesia: Sources of variability and methods for reduction. J Pain Symptom Manage 1998;16:10–20.

13. Mohammadian P, Andersen OK, Arendt-Nielsen L. Correlation between local vascular and sensory changes following tissue inflammation induced by repetitive application of topical capsaicin. Brain Res 1998;792:1–9.

14. Wasner G, Baron R, Janig W. Dynamic mechanical allodynia in humans is not mediated by a central presynaptic interaction of A beta-mechanoreceptive and nociceptive C-afferents. Pain 1999;79:113–119.

15. Takahashi Y, Murata A, Nakajima Y. Dilatation of subcutaneous perforating blood vessels associated with capsaicin-induced cutaneous axon reflex: Demonstration with subtraction thermography. J Auton Nerv Syst 1999;75: 87–92.

16. Baron R, Wasner G, Borgstedt R, et al. Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation. Neurology 1999;52:923–932.

17. Andrews K, Baranowski A, Kinnman E. Sensory threshold changes without initial pain or alterations in cutaneous blood flow, in the area of secondary hyperalgesia caused by topical application of capsaicin in humans. Neurosci Lett 1999;266:45–48.

18. Fuchs PN, Campbell JN, Meyer RA. Secondary hyperalgesia persists in capsaicin desensitized skin. Pain 2000; 84:141–149.

19. Sumikura H, Andersen OK, Drewes AM, Arendt-Nielsen

L. Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin. Pain 2003;105:285–291.

20. Sumikura H, Andersen OK, Drewes AM, Arendt-Nielsen

L. A comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans. Neurosci Lett 2003;337:147–150.

21. Gazerani P, Andersen OK, Arendt-Nielsen L. Site-specific, dose-dependent, and sex-related responses to the experimental pain model induced by intradermal injection of capsaicin to the foreheads and forearms of healthy humans. J Orofac Pain 2007;21:289–302.

22. Lawless HT, Stevens DA. Responses by humans to oral chemical irritants as a function of locus of stimulation. Percept Psychophys 1988;43:72–78.

23. Green BG. Capsaicin desensitization and stimulus-induced recovery on facial compared to lingual skin. Physiol Behav 1998;65:517–523.

24. Said YS, Ellrich J. Quantitative sensory testing in the orofacial region. Acta Physiol 2007;189(suppl 653):P20-L1-05.

25. Bautista DM, Movahed P, Hinman A, et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A 2005;102:12248–12252.

26. Hargreaves KM, Keiser K. Development of new pain management strategies. J Dent Educ 2002;66:113–121.

27. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 2003;17:301–310.

28. Motl RW, O’Connor PJ, Dishman RK. Effect of caffeine on perceptions of leg muscle pain during moderate intensity cycling exercise. J Pain 2003;4:316–321.

29. Melzack R. The McGill pain questionnaire: Major properties and scoring methods. Pain 1975;1:277–299.

30. Heden P, Jurell G, Arnander C. Prediction of skin flap necrosis: A comparative study between laser Doppler flowmetry and fluorescein test in a rat model. Ann Plast Surg 1986;17:485–488.

31. Carpentier PH. New techniques for clinical assessment of the peripheral microcirculation. Drugs 1999;59:17–22.

32. Choi CM, Bennett RG. Laser dopplers to determine cutaneous blood flow. Dermatol Surg 2003;29:272–280.

33. Herrick AL, Hutchinson C. Vascular imaging. Best Pract Res Clin Rheumatol 2004;18:957–979.

34. Wright CI, Kroner CI, Draijer R. Non-invasive methods and stimuli for evaluating the skin’s microcirculation. J Pharmacol Toxicol Methods 2006;54:1–25.

35. Ishida Y, Ugawa S, Ueda T, Murakami S, Shimada S. Vanilloid receptor subtype-1 (VR1) is specifically localized to taste papillae. Brain Res Mol Brain Res 2002;107: 17–22.

36. Honda K, Kitagawa J, Sessle BJ, et al. Mechanisms involved in an increment of multimodal excitability of medullary and upper cervical dorsal horn neurons following cutaneous capsaicin treatment. Mol Pain 2008;4:59.

37. Noma N, Tsuboi Y, Kondo M, et al. Organization of pERK-immunoreactive cells in trigeminal spinal nucleus caudalis and upper cervical cord following capsaicin injection into oral and craniofacial regions in rats. J Comp Neurol 2008;507:1428–1440.

38. Green BG, Gelhard B. Perception of temperature on oral and facial skin. Somatosens Res 1987;4:191–200.

39. Gazerani P, Andersen OK, Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization: Gender-specific differences. Pain 2005;118:155–163.

40. Gazerani P, Staahl C, Drewes AM, Arendt-Nielsen L. The effects of botulinum toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization. Pain 2006; 122:315–325.

41. Kupers RC, Chen CC, Bushnell MC. A model of transient hyperalgesia in the behaving monkey induced by topical application of capsaicin. Pain 1997;72:269–275.

42. Baad-Hansen L, Jensen TS, Svensson P. A human model of intraoral pain and heat hyperalgesia. J Orofac Pain 2003;17:333–340.

43. Culp WJ, Ochoa J, Cline M, Dotson R. Heat and mechanical hyperalgesia induced by capsaicin: Cross modality threshold modulation in human C nociceptors. Brain 1989;112:1317–1331.

44. Crouzet C, Fournier H, Papon X, Hentati N, Cronier P, Mercier P. Anatomy of the arterial vascularization of the lips. Surg Radiol Anat 1998;20:273–278.

45. Kemppainen P, Leppanen H, Jyvasjarvi E, Pertovaara A. Blood flow increase in the orofacial area of humans induced by painful stimulation. Brain Res Bull 1994; 33:655–662.

46. Kemppainen P, Forster C, Handwerker HO. The importance of stimulus site and intensity in differences of pain-induced vascular reflexes in human orofacial regions. Pain 2001;91:331–338.